Faria Maria Luiza Medeiros, Libório Alexandre Braga
Medical Program, Universidade de Fortaleza-UNIFOR, Fortaleza, Ceará, Brazil.
Medical Sciences Postgraduate Program, Universidade de Fortaleza- UNIFOR, Fortaleza, Ceará, Brazil.
Shock. 2025 Feb 1;63(2):202-209. doi: 10.1097/SHK.0000000000002435. Epub 2024 Aug 12.
Background : Continuous kidney replacement therapy (CKRT) is a crucial intervention for hemodynamically unstable patients with acute kidney injury (AKI). Despite the recommendations to offer a CKRT dose of 20 to 25 mL/kg/h, the optimal CKRT dose remains uncertain, especially whether low-dose CKRT is associated with poor outcomes. This study investigated the association between low CKRT dosage and 90-day mortality using a marginal structural model (MSM). Methods : Using the MIMIC-IV database, adult patients who received CKRT for more than 24 h were included. Data on time-fixed and time-dependent variables were collected. Patients were categorized based on CKRT dose thresholds of 13 and 20 mL/kg/h. Results : Among the 1,329 patients, the 90-day mortality rate was 49.6%. The median age of the patients was 62 years (IQR: 52-72). Changes in CKRT dosing during treatment were frequent. Patients with a reduced delivered CKRT dose (<20 and <13 mL/kg/h) generally exhibited low values during the initial days of CKRT, with an increase in the delivered CKRT dose. After adjusting only for baseline variables (traditional Cox regression model), patients receiving CKRT doses <13 mL/kg/h had significantly greater 90-day mortality (HR: 1.70, 95% CI 1.16-2.49) than those receiving CKRT doses ≥13 mL/kg/h. However, after adjusting for time-dependent variables, the CKRT dose was not significantly associated with mortality at either the 13 or 20 mL/kg/h threshold. Additionally, there were no significant associations between the delivered CKRT dose and 90-day mortality within the range of 5 to 40 mL/kg/h. Conclusion : This study highlights the impact of methodological approaches on the association between CKRT dose and mortality and that with personalized adjustments, there may not be a lower limit of the unsafe CKRT dose. However, lower CKRT doses were initially associated with higher mortality, and adjusting for time-dependent variables nullified this association.
连续性肾脏替代疗法(CKRT)是对血流动力学不稳定的急性肾损伤(AKI)患者的关键干预措施。尽管建议给予20至25 mL/kg/h的CKRT剂量,但最佳CKRT剂量仍不确定,尤其是低剂量CKRT是否与不良预后相关。本研究使用边际结构模型(MSM)调查了低CKRT剂量与90天死亡率之间的关联。方法:使用MIMIC-IV数据库,纳入接受CKRT超过24小时的成年患者。收集关于时间固定和时间依赖变量的数据。根据13和20 mL/kg/h的CKRT剂量阈值对患者进行分类。结果:在1329例患者中,90天死亡率为49.6%。患者的中位年龄为62岁(四分位间距:52 - 72岁)。治疗期间CKRT剂量的变化很频繁。接受的CKRT剂量降低(<20和<13 mL/kg/h)的患者在CKRT开始的几天内通常显示较低的值,随后接受的CKRT剂量增加。仅对基线变量进行调整后(传统Cox回归模型),接受CKRT剂量<13 mL/kg/h的患者90天死亡率(风险比:1.70,95%置信区间1.16 - 2.49)显著高于接受CKRT剂量≥13 mL/kg/h的患者。然而,在对时间依赖变量进行调整后,在13或20 mL/kg/h阈值下,CKRT剂量与死亡率均无显著关联。此外,在5至40 mL/kg/h范围内,接受的CKRT剂量与90天死亡率之间也无显著关联。结论:本研究强调了方法学方法对CKRT剂量与死亡率之间关联的影响,并且通过个性化调整,可能不存在不安全CKRT剂量的下限。然而,较低的CKRT剂量最初与较高的死亡率相关,而对时间依赖变量进行调整消除了这种关联。